Ariane Gabrielli Massalaka Rublesperger
Datos Biográficos
| ID | 8934151 |
|---|---|
| NOMBRE | Ariane Gabrielli Massalaka Rublesperger |
| NOMBRES | Ariane Gabrielli Massalaka |
| APELLIDO | Rublesperger |
| FIRMA | RUBLESPERGER A G M |
| AFILIACIONES | Universidade Estadual de Ponta Grossa |
| ORCID | 0009-0004-6830-5553 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2026 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Evidence for the efficacy and safety of pre-exposure prophylaxis (PrEP) in all populations
PrEP (pre-exposure prophylaxis) is a medication used to prevent HIV infection, with the combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) being the most commonly used formulation. This review aims to evaluate the efficacy and safety of PrEP across various populations based on recent studies. Studies published in English, Portuguese, or Spanish from 2018 to 2023 that provided data on HIV incidence or adverse events (AEs) a…
Sin obras prominentes en esta página.
Evidence for the efficacy and safety of pre-exposure prophylaxis (PrEP) in all populations
PrEP (pre-exposure prophylaxis) is a medication used to prevent HIV infection, with the combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) being the most commonly used formulation. This review aims to evaluate the efficacy and safety of PrEP across various populations based on recent studies. Studies published in English, Portuguese, or Spanish from 2018 to 2023 that provided data on HIV incidence or adverse events (AEs) a…
Adverse effect (1 obra) · Emtricitabine (1 obra) · HIV-related health complications and treatments (1 obra) · HIV/AIDS Research and Interventions (1 obra) · Pre-exposure prophylaxis (1 obra) · Reproductive tract infections research (1 obra) · Tenofovir (1 obra)